Feedback / Questions
BBO-10203 - BridgeBio Oncology Therapeutics
https://www.globenewswire.com/news-release/2025/12/10/3203501/0/en/BBOT-Announces-Late-Breaking-Preclinical-Data-on-BBO-10203-a-First-in-Class-RAS-PI3K%CE%B1-Breaker-at-the-San-Antonio-Breast-Cancer-Symposium-SABCS.html
Dec 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next